Teva

20 stories about Teva
אורי טל טנא פרשן שוק ההון

Teva Wants to Be Like Mylan: Agile, Lean and Profitable

17.12.17|Uri Tal-Tenne
The cost-cutting plan revealed Thursday by Teva CEO Kåre Schultz showcases an intention to transform Teva into a lean and efficient generic drug company, much like main competitor Mylan
מנכ"ל טבע החדש קור שולץ

Teva Might Have Been Better Off as a Smaller Company, new CEO Says

17.12.17|Dror Reich
The generic drugs powerhouse is now carrying a $34.7 billion debt—a result of a $40.5 acquisition of Actavis. New CEO Kåre Schultz presented a detailed restructuring plan on Thursday
אחרי ה שביתה נתב"ג טבע פיטורים טיסות טרמינל

Tel Aviv Airport, Stock Market Open as Solidarity Strike Ends

17.12.17|Lior Gutman, Omri Milman and Micky Grunfeld
Israel’s largest labor union called for a half-day strike on Thursday, in support of Teva employees
עובדי חברת טבע ב ירושלים מפגינים נגד ה פיטורים

CTech’s Weekly Israeli Tech News Roundup

15.12.17|CTech
How the Teva drama unfolded. Israeli judge orders Facebook to reinstate a terminated page. Israeli regulator blocks crypto-mining company
עובדי חברת טבע ב ירושלים מפגינים נגד ה פיטורים

CTech’s Daily Israeli Tech News Roundup

14.12.17|CTech
How the Teva drama unfolded. Kochs to invest up 150 million in InSightec. Bitcoin to be discussed in the Israeli parliament for the first time ever
עובדי טבע בקריית שמונה מפגינים

Employees Protest Outside Teva’s Israeli Facilities

14.12.17|Omer Kabir, Yoav Stoler and Keren-Or Grinberg
The demonstrations outside the company's facilities held Thursday foreshadow a full-out strike planned by the company’s employees for Sunday
מנכ"ל טבע החדש קור שולץ 2

Teva to Let Go 14,000 Employees Over the Next Two Years

14.12.17|Lilach Baumer
The company released a statement detailing its reconstruction plan Thursday. CEO Kåre Schultz elaborated on the plan during a call with investors
פסקל סוריו מנכ"ל AstraZeneca

Once Future CEO Could have Taken Teva on a Different Path

14.12.17|Lilach Baumer, Golan Hazani, and Orr Hirschauge
AstraZeneca CEO Pascal Soriot, which backed out of Teva’s CEO position in July, planned on taking the company towards innovation instead of generic focus
אבי ניסנקורן מסיבת עיתונאים טבע פיטורים

Israeli Union Leader Calls for General Strike on Expected Teva Cutback Reports

14.12.17|Dror Reich, Sefi Krupsky, and Adrian Filut
On Wednesday, Calcalist reported Teva intends to terminate over half of its employees in Israel in the next months
מפעל טבע הר חוצבים ירושלים

CTech’s Daily Israeli Tech News Roundup

13.12.17|CTech
Teva to fire half of its Israeli workforce, relocate Israel-based manufacturing operations. The European Investment Fund renews its backing for Israeli tech. Automotive cybersecurity startup Upstream raises $9 Million.
מנכ"ל טבע החדש קור שולץ 2

Teva to Cut Around Half of Israeli Workforce, Outsource Operations

13.12.17|Dror Reich
An internal document reviewed by Calcalist reveals the troubled drugmaker's detailed domestic cost-cutting plans
מפעל טבע טק ב רמת חובב

Teva to Cut Jobs, Shut Down Some Israeli Operations

13.12.17|Dror Reich and Sefi Krupsky
On Thursday, the troubled drugmaker is expected to unveil its cutback plan. At its center is extensive layoffs and the reorganization and divestment of non-core assets
יצחק פטרבורג

Former Chairman Yitzhak Peterburg Leaves Teva

13.12.17|Lilach Baumer
Mr. Peterburg was the troubled drugmaker's interim CEO between February and November 1, when Kåre Schultz took helm
בורסה בורסת תל אביב

CTech’s Daily Israeli Tech News Roundup

12.12.17|CTech
The Israeli regulator blocks cryptocoins company Natural Resource Holdings out of Tel Aviv stock exchange indices. WeWork just leased its largest ever coworking space. Teva to unveil strategic plan, layoffs on Thursday
מנכ"ל טבע החדש קור שולץ 1

Teva to Unveil Strategic Plan, Layoffs Thursday

12.12.17|Dror Reich
Last month the debt-riddled drug maker announced a rehabilitation plan amidst rumors of upcoming employee cuts
ההכרזה של דולנד טראמפ על ירושלים 2

CTech’s Daily Israeli Tech News Roundup

10.12.17|CTech
Backlash against Trump’s Jerusalem declaration has reached Israeli tech. AmTrust is planning a listing on Tel Aviv Stock Exchange. Teva’s stock is up following news of more layoffs.
מפעל טבע נתניה

Teva’s Stock Jumps Following Report on Planned Cuts

10.12.17|Dror Reich and Lilach Baumer
On Friday, Bloomberg reported that Teva might be slashing as many as 10,000 jobs, citing sources. Last month, Calcalist reported Teva is planning to cut over 4,000 jobs in the U.S. and Israel
לוגו ctech

CTech’s Weekly Israeli Tech News Roundup

01.12.17|CTech
Amazon’s plans to open local distribution center, Uber’s retreated after facing legal pressure, and Teva is going back to its roots
לוגו ctech

CTech’s Daily Israeli Tech News Roundup

30.11.17|CTech
VC firm NFX wants to change the world (or at least the VC industry), Teva’s troubles just don’t seem to end (this time it’s a potential derivative action lawsuit) and Deloitte publishes its Israel Technology Fast 50 list, which has old industry veterans and some newcomers
חברת ה תרופות טבע Teva

Fresh Teva Lawsuit Goes Against Dividends Paid by Debt Heavy Drugmaker

30.11.17|Anat Rouah
Tel Aviv-based capital investment firm Tulip Capital is threatening derivative action against Teva, saying the company's huge debt load renders its dividends unlawful